Vinge advised Infant Bacterial Therapeutics AB on the offering. Infant Bacterial Therapeutics AB (publ) completed its rights offering of approximately SEK 100 million. IBT is addressing...
You must be a Standard 1 Year member to access this content.
Vinge advised François-Charles Oberthur on the deal, while Delphi advised Rolling Optics. François-Charles Oberthur SAS announced a cash offer to the holders of ordinary shares, preference shares,...
You must be a Standard 1 Year member to access this content.
Roschier represented Bonnier News in the transaction. Vinge advised Cafeyn Group. Wigge & Partners advised Readly International AB. Bonnier News has announced a public offer of...
You must be a Standard 1 Year member to access this content.
Vinge advised Aneo on the deal. Cirio advised Scandinavian Biogas. Aneo Renewables Holding AS (“Aneo”) has announced a mandatory cash tender offer for the shares in...
You must be a Standard 1 Year member to access this content.
Cirio advised Scandinavian Biogas Fuels International AB on the deal while Vinge advised Aneo. The board of directors of Scandinavian Biogas resolved, subject to subsequent approval...
You must be a Standard 1 Year member to access this content.
Vinge advised Semcon AB on the deal. Ratos AB announced a recommended public cash offer to the shareholders of Semcon AB to tender all their shares in Semcon...
You must be a Standard 1 Year member to access this content.
Vinge has advised Semcon AB on the deal. Etteplan Oyj announced a recommended public offer to the shareholders of Semcon AB to tender all their shares in Semcon at...
You must be a Standard 1 Year member to access this content.
Roschier represented Karo Pharma in the deal. White & Case advised EQT, through EQT VIII and Karo Intressenter. Vinge has advised Nordea Bank Abp, filial i...
You must be a Standard 1 Year member to access this content.
Vinge advised Active Biotech on the deal. Active Biotech AB (publ) (Nasdaq Stockholm) carried out a rights issue of approximately SEK 55 million. Active Biotech is a...
You must be a Standard 1 Year member to access this content.
Vinge advised Cantargia AB on the deal. Cantargia AB announced a fully covered new share issue of approximately SEK 250 million with pre-emptive rights for the Company’s...
You must be a Standard 1 Year member to access this content.
Vinge advised Öhlin Holding on the deal. KANTER has assisted myFC Holding. K Öhlin Holding has announced a recommended public takeover offer to the shareholders in...
You must be a Standard 1 Year member to access this content.
Noerr, Ropes & Gray and Vinge advised SAF-HOLLAND on the deal. Clifford Chance has advised UniCredit and Helaba Landesbank Hessen-Thüringen, while Baker McKenzie advised Knorr-Bremse AG....
You must be a Standard 1 Year member to access this content.
